| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-214 | Cisplatin | ovarian cancer | Resistant | Low | 18199536 | |
| miR-214 | Cisplatin | ovarian cancer | Resistant | High | 19074899 | |
| miR-216 | Cisplatin | ovarian cancer | Resistant | High | 19074899 | |
| miR-21 | Cisplatin | breast cancer | Resistant | Low | 19082437 | |
| miR-214 | Cisplatin | breast cancer | Sensitive | High | 20099276 | |
| miR-21 | Cisplatin | tongue squamous cell carcinoma | Resistant | High | 20219416 | |
| miR-214 | Cisplatin | tongue squamous cell carcinoma | Resistant | High | 20219416 | |
| miR-21 | Cisplatin | esophageal cancer | Sensitive | High | 21248297 | |
| miR-21 | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 21289630 | |
| miR-21 | Cisplatin | germ cell tumor | Sensitive | High | 21575166 | |
| miR-218 | Cisplatin | germ cell tumor | Sensitive | High | 21575166 | |
| miR-218 | Cisplatin | germ cell tumor | Sensitive | High | 21575166 | |
| miR-21 | Cisplatin | head and neck squamous cell carcinoma | Sensitive | Low | 21685938 | |
| miR-210 | Cisplatin | ehrlich ascites tumor | Resistant | High | 21899346 | |
| miR-21 | Cisplatin | non-small cell lung cancer | Resistant | Low | 22237007 | |
| miR-21 | Cisplatin | oral squamous cell carcinoma | Resistant | Low | 22249446 | |
| miR-218 | Cisplatin | Bladder Carcinoma | Sensitive | High | 22954303 | |
| miR-21 | Cisplatin | non-small cell lung cancer | Resistant | Low | 22956424 | |
| miR-214 | Cisplatin | ovarian cancer | Sensitive | High | 23045278 | |
| miR-215 | Cisplatin | ovarian cancer | Sensitive | High | 23045278 | |
| miR-21 | Cisplatin | neuroblastoma | Resistant | Low | 23084187 | |
| miR-214 | Cisplatin | cervical cancer | Sensitive | Low | 23337879 | |
| miR-218 | Cisplatin | cervical cancer | Sensitive | Low | 23443110 | |
| miR-21 | Cisplatin | gastric cancer | Resistant | Low | 23466500 | |
| miR-210 | Cisplatin | gastric cancer | Sensitive | High | 23525256 | |
| miR-21 | Cisplatin | ovarian cancer | Resistant | Low | 23824073 | |
| miR-214 | Cisplatin | squamous cell carcinoma | Resistant | High | 23831023 | |
| miR-21 | Cisplatin | nasopharyngeal carcinoma | Resistant | Low | 24194922 | |
| miR-21 | Cisplatin | ovarian cancer | Resistant | Low | 24472409 | |
| miR-21 | Cisplatin | tongue squamous cell carcinoma | Resistant | Low | 24609942 | |
| miR-21 | Cisplatin | ovarian cancer | Resistant | High | 24659709 | |
| miR-21 | Cisplatin | ovarian cancer | Sensitive | Low | 24865582 | |
| miR-21 | Cisplatin | non-small-cell lung cancer | Resistant | Low | 24906642 | |
| miR-218 | Cisplatin | gastric cancer | Sensitive | Low | 25170221 | |
| miR-217 | Cisplatin | lung cancer | Sensitive | Low | 25234467 | |
| miR-21 | Cisplatin | lung cancer | Resistant | Low | 25323306 | |
| miR-21 | Cisplatin | osteosarcoma | Resistant | Low | 25381586 | |
| miR-214 | Cisplatin | breast cancer | Sensitive | High | 25394901 | |
| miR-218 | Cisplatin | breast cancer | Sensitive | Low | 25394901 | |
| miR-21 | Cisplatin | oral squamous cell carcinoma | Associated | Low | 25514838 | |
| miR-21 | Cisplatin | ovarian cancer | Resistant | Low | 25579119 | |
| miR-21 | Cisplatin | ovarian cancer | Sensitive | High | 26043084 | |
| miR-215 | Cisplatin | ovarian cancer | Resistant | High | 26261572 | |
| miR-21 | Cisplatin | glioma | Resistant | High | 26323558 | |
| miR-21 | Cisplatin | glioma | Resistant | High | 26323558 | |
| miR-21 | Cisplatin | small cell lung cancer | Sensitive | High | 26676926 |